Question 1

What is the typical CAPEX range for setting up a Nefazodone Hydrochloride manufacturing plant?

Accepted Answer

The indicative CAPEX range is USD 12 million to USD 50 million for a cGMP nefazodone hydrochloride API plant producing about 2 to 30 metric tons per year.

Question 2

What is the typical plant capacity or benchmark scale for a Nefazodone Hydrochloride manufacturing facility?

Accepted Answer

The benchmark plant capacity is 2 to 30 metric tons of API per year.

Question 3

What is the current market size and growth rate for Nefazodone Hydrochloride?

Accepted Answer

The market size is estimated to be in the low tens of millions of dollars and is expected to remain stable or decline slowly over time.

Question 4

What are the main end-use segments for Nefazodone Hydrochloride, and what share of demand does each represent?

Accepted Answer

Residual generic use for depression accounts for around 70% to 85% of demand. Reference-standard and research use accounts for around 5% to 10%, second-line and specialist prescribing represents around 5% to 10%, and other or legacy uses make up around 5% to 10%.

Question 5

What is the reaction or synthesis route and key intermediates used to manufacture Nefazodone Hydrochloride?

Accepted Answer

The process uses a multi-step chemical synthesis that couples a chlorophenylpiperazine unit and a triazolone unit through a propyl and phenoxyethyl chain to form nefazodone, which is then converted into the hydrochloride salt. Key intermediates include the chlorophenylpiperazine unit and a triazolone building block.

Question 6

What are the key intermediate or API cost requirements, and what share of raw material cost do they represent?

Accepted Answer

The chlorophenylpiperazine unit and triazolone building block are the main raw material cost drivers and are estimated to account for around 55% to 70% of total raw material costs.

Question 7

What share of total capital cost do the core reaction and purification equipment represent?

Accepted Answer

Core process equipment, including jacketed reactors, distillation and extraction units, filtration and drying systems, and milling and packing lines, represents 40% to 55% of the total plant setup cost.

Question 8

What factors drive Nefazodone Hydrochloride manufacturing cost the most?

Accepted Answer

Nefazodone hydrochloride production costs are mainly driven by cGMP compliance, quality control, process yield, and the cost of specialty intermediates. Quality and compliance activities can account for around 10% to 15% of operating costs.

Question 9

In which regions is Nefazodone Hydrochloride manufacturing capacity concentrated?

Accepted Answer

API and generic manufacturing capacity is mainly located in the United States, India, and China.

Question 10

What grades or specifications are available for Nefazodone Hydrochloride?

Accepted Answer

Nefazodone hydrochloride is a white crystalline powder with a melting point of about 186 to 188 degree Celsius. Pharmaceutical-grade API, bulk API, and reference-standard material are the main specifications used for regulated and research applications.

Question 11

What regulatory requirements (FDA, EMA, GMP, DMF filings) apply to Nefazodone Hydrochloride manufacturing?

Accepted Answer

Manufacturing requires cGMP compliance, validated processes, quality testing, regulatory approvals, and controlled documentation. FDA, EMA, and DMF requirements may apply depending on the target market and regulatory filing.

Nefazodone Hydrochloride Manufacturing Plant Project Report 2026: Cost Analysis, ROI, and Feasibility Insights

About the Author

Vishakha Agrawal

Frequently Asked Questions